SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Pfizer Inc.: Adding Inspra(R) (eplerenone) To Standard Therapy Reduces The Incidence Of New Onset Atrial Fibrillation/Flutter (AF/F) In Patients With Systolic Heart Failure, Sub-Analysis Shows